Literature DB >> 11875294

Microalbuminuria in essential hypertension: redefining the threshold.

Josep Redon, Bryan Williams.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11875294     DOI： 10.1097/00004872-200203000-00002

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  7 in total

1.  Relationship between left ventricular hypertrophy, hypertensive retinopathy, microalbuminuria and echocardiographic modalities in newly diagnosed hypertensive patients.

Authors:  Ahmet Kaya Bilge; Dursun Atilgan; Imran Onur; Burak Pamukcu; Mustafa Ozcan; Kâmil Adalet
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-29       Impact factor: 2.357

Review 2.  Proteinuria: an underappreciated risk factor in cardiovascular disease.

Authors:  Julián Segura; Carlos Campo; Luis M Ruilope
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

Review 3.  Microalbuminuria in hypertension.

Authors:  Paolo Palatini
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 4.  [Hypertensive heart disease and microangiopathy].

Authors:  M Kelm; B E Strauer
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

5.  Urine albumin excretion, within normal range, reflects increasing prevalence of metabolic syndrome in patients with essential hypertension.

Authors:  Gregory Vyssoulis; Eva Karpanou; Pangiotis Spanos; Stella-Maria Kyvelou; Dionysios Adamopoulos; Christodoulos Stefanadis
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-08       Impact factor: 3.738

6.  Cardiovascular and Renal Links along the Cardiorenal Continuum.

Authors:  José A García-Donaire; Luis M Ruilope
Journal:  Int J Nephrol       Date:  2011-03-31

7.  The relationship between urinary albumin to creatinine ratio and all-cause mortality in the elderly population in the Chinese community: a 10-year follow-up study.

Authors:  Anhang Zhang; Man Li; Jiaojiao Qiu; Jin Sun; Yongkang Su; Shuang Cai; Qiligeer Bao; Bokai Cheng; Shouyuan Ma; Yan Zhang; Shuxia Wang; Ping Zhu
Journal:  BMC Nephrol       Date:  2022-01-05       Impact factor: 2.388
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.